Abstract:Abstract Despite the vital activity of many compounds, they lack that effectiveness due to their low solubility in water. Unfortunately, for this reason, rutin often leads to low tissue permeability and insufficient bioavailability, which has greatly limited its pharmacological utility. Therefore, the present investigation is designed to overcome this problem by formulating the rotin to rotin nanocrystals (RNCs) with studying their some pharmacological applications in vitro and in silico. RNCs were created via the ultrasonication approach and showed a spherical shape via Transmission electron microscopy with a mean particle size of 27 nm. RNCs reflected inhibitory action against Helicobacter pylori with an inhibition zone (IZ) of 22.67 mm compared to rutin (IZ of 18 mm) and standard control (IZ of 19.5 mm). RNCs exhibited less minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) (7.8 μg/mL) than rutin (62.5 μg/mL). The MBC/MIC index of rutin and RNCs indicated their bactericidal properties. RNCs were more acutely ( 92.12%) than rutin (85.43%) for inhibition the H. pylori biofilm formation. A promising half maximal inhibitory concentration (IC 50 ) (6.85 μg/mL) was recorded using RNCs for urease inhibition compared to the IC 50 value of rutin (97.8 μg/mL). The activity of rutin and RNCs was tested against cancer cells of human colon cancer (HT-29) and normal Vero cells. IC 50 values of RNCs were less 168.23 ± 1.15 μg/mL and 297.69 ± 4.23 μg/mL than the IC 50 values of rutin 184.96 ± 4.33 μg/mL and 335.31 ± 2.02 μg/mL against HT-29 cells and normal Vero cells, respectively. Different percentages (72.2, 77.3, and 81.9%) of hemolysis inhibition were recorded using RNCs, but 63.6, 68.9, 73.6, and 80.6% were obtained using rutin at 600, 800, and 1000 μg/mL, respectively. Butyrylcholinesterase (BChE) inhibition % was documented at a lower IC 50 value for RNCs (12.74 μg/mL) than the IC 50 of rutin (18.15 μg/mL). The target molecule underwent molecular docking research against H. pylori [Protein Data Bank (PDB) code: 4HI0], HT-29 cells (PDB code: 2HQ6), and BChE (PDB code: 6EMI) in order to enhance the interactions between rutin and the chosen receptors and to estimate its molecular operating environment (MOE) affinity scoring. Rutin has predicted strong binding interactions and potent activity against the examined proteins 4HI0, 2HQ6, and 6EMI with low binding scores of − 7.47778 kcal/mol, − 7.68511 kcal/mol, and − 9.50333 kcal/mol, respectively.

Antivirulence activities of Rutin-loaded chitosan nanoparticles against pathogenic Staphylococcus aureus

Inhibition of Virulence Properties of Pathogenic Pseudomonas aeruginosa by Rutin-Loaded Chitosan Nanoparticles

Rutin-coated zinc oxide nanoparticles: a promising antivirulence formulation against pathogenic bacteria

Inhibitory potential of rutin and rutin nano-crystals against Helicobacter pylori, colon cancer, hemolysis and Butyrylcholinesterase in vitro and in silico

Antibacterial Effect of Co-Loaded Curcumin and Rutin in Mesoporous Silica Nanoparticles Compared to their Loading Alone

Development of Gum-Acacia-Stabilized Silver Nanoparticles Gel of Rutin against Candida albicans

Solid Lipid Nanoparticles Enhance Protective Effect of Rutin against STZ-Induced Neurotoxicity in PC12 Cells through Autophagy Suppression

Assessment of Antimicrobial Activity of Chitosan, ZnO, and Urtica dioica-ZnO NPs Against Staphylococcus aureus Isolated from Diabetic Ulcers

Formulation and Characterization of Rutin Loaded Chitosan Nanoparticles

Synergistic Action of Rutin‐Coated Zinc Oxide Nanoparticles: Targeting Biofilm Formation Receptors of Dental Pathogens and Modulating Apoptosis Genes for Enhanced Oral Anticancer Activity

Inhibition of Staphylococcus aureus α-Hemolysin Production Using Nanocurcumin Capped Au@ZnO Nanocomposite

Hesperidin inhibits biofilm formation, virulence and staphyloxanthin synthesis in methicillin resistant Staphylococcus aureus by targeting SarA and CrtM: an in vitro and in silico approach

Nanophytosomes for enhancement of rutin efficacy in oral administration for diabetes treatment in streptozotocin-induced diabetic rats

Rutin, A Natural Inhibitor of IGPD Protein, Partially Inhibits Biofilm Formation in Staphylococcus xylosus ATCC700404 in vitro and in vivo

Fabrication and antimicrobial properties of novel meropenem-honey encapsulated chitosan nanoparticles against multiresistant and biofilm-forming Staphylococcus aureus as a new antimicrobial agent

Synthesis and Characterization of Chitosan/Silver Nanocomposite Using Rutin for Antibacterial, Antioxidant and Photocatalytic Applications

Therapeutic benefits of rutin and its nanoformulations

Rutin-gallium complex mediated antimicrobial photodynamic therapy: An in vitro studies against Streptococcus mutans biofilms

Biological Safety and Antibacterial Properties of Chitosan Nanoparticles Against Staphylococcus Aureus

Nanoparticles Self-Assembled from Berberine and Chrysin for Generating Antimicrobial Films

Nano-Rutin: A Promising Solution for Alleviating Various Disorders